British Columbia Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53M Sell
243,587
-69,837
-22% -$15.5M 0.31% 57
2025
Q4
$71.6M Buy
313,424
+59,092
+23% +$13.5M 0.38% 46
2025
Q3
$58.9M Sell
254,332
-24,367
-9% -$4.96M 0.34% 59
2025
Q2
$51.7M Sell
278,699
-59,257
-18% -$11M 0.3% 73
2025
Q1
$70.8M Sell
337,956
-282
-0.1% -$54.8K 0.44% 51
2024
Q4
$60.1M Buy
338,238
+43,594
+15% +$8.02M 0.36% 54
2024
Q3
$58.2M Sell
294,644
-44,511
-13% -$8.31M 0.35% 56
2024
Q2
$58.2M Buy
339,155
+127,638
+60% +$21.1M 0.35% 53
2024
Q1
$38.5M Buy
211,517
+8,340
+4% +$1.44M 0.27% 79
2023
Q4
$31.5M Buy
203,177
+42,636
+27% +$6.22M 0.26% 83
2023
Q3
$23.9M Buy
160,541
+1,134
+0.7% +$166K 0.23% 86
2023
Q2
$21.5M Buy
159,407
+1,271
+0.8% +$186K 0.2% 97
2023
Q1
$25.2M Buy
158,136
+1,231
+0.8% +$188K 0.26% 72
2022
Q4
$25.4M Sell
156,905
-18,205
-10% -$2.79M 0.28% 72
2022
Q3
$23.5M Sell
175,110
-30,383
-15% -$4.36M 0.26% 73
2022
Q2
$31.5M Sell
205,493
-67,866
-25% -$10.4M 0.3% 67
2022
Q1
$44.3M Sell
273,359
-37,413
-12% -$5.43M 0.28% 67
2021
Q4
$42.1M Sell
310,772
-15,845
-5% -$1.87M 0.24% 80
2021
Q3
$35.2M Sell
326,617
-258
-0.1% -$29.5K 0.21% 88
2021
Q2
$36.8M Buy
326,875
+36,981
+13% +$4.16M 0.23% 85
2021
Q1
$31.4M Sell
289,894
-8,923
-3% -$954K 0.23% 85
2020
Q4
$32M Sell
298,817
-7,967
-3% -$766K 0.22% 93
2020
Q3
$26.9M Buy
306,784
+23,566
+8% +$2.22M 0.22% 95
2020
Q2
$27.8M Buy
283,218
+121,312
+75% +$10.7M 0.28% 79
2020
Q1
$12.3M Sell
161,906
-186,978
-54% -$15.9M 0.21% 97
2019
Q4
$30.9M Sell
348,884
-150,889
-30% -$12.5M 0.23% 99
2019
Q3
$37.8M Sell
499,773
-48,062
-9% -$3.3M 0.37% 67
2019
Q2
$39.8M Buy
547,835
+77,919
+17% +$6.12M 0.35% 67
2019
Q1
$37.9M Sell
469,916
-125,630
-21% -$10.3M 0.34% 76
2018
Q4
$54.9M Buy
595,546
+20,596
+4% +$1.81M 0.49% 45
2018
Q3
$54.4M Sell
574,950
-189,598
-25% -$18M 0.58% 34
2018
Q2
$70.8M Buy
764,548
+89,019
+13% +$8.69M 0.62% 33
2018
Q1
$63.9M Sell
675,529
-20,274
-3% -$2.23M 0.49% 43
2017
Q4
$67.3M Buy
695,803
+44,130
+7% +$4.16M 0.47% 43
2017
Q3
$57.9M Buy
651,673
+4,995
+0.8% +$380K 0.45% 51
2017
Q2
$46.9M Sell
646,678
-67,472
-9% -$4.54M 0.37% 53
2017
Q1
$46.5M Sell
714,150
-14,565
-2% -$916K 0.37% 54
2016
Q4
$45.6M Buy
728,715
+106,548
+17% +$6.5M 0.4% 53
2016
Q3
$39.2M Sell
622,167
-116,297
-16% -$7.53M 0.4% 53
2016
Q2
$45.7M Sell
738,464
-4,719
-0.6% -$288K 0.4% 52
2016
Q1
$42.5M Buy
743,183
+9,528
+1% +$531K 0.4% 53
2015
Q4
$43.5M Sell
733,655
-27,205
-4% -$1.57M 0.42% 53
2015
Q3
$41.4M Sell
760,860
-27,261
-3% -$1.77M 0.42% 53
2015
Q2
$53M Buy
788,121
+14,203
+2% +$927K 0.5% 44
2015
Q1
$45.3M Sell
773,918
-36,191
-4% -$2.19M 0.41% 53
2014
Q4
$53M Buy
810,109
+16,235
+2% +$1.02M 0.44% 52
2014
Q3
$45.9M Sell
793,874
-5,901
-0.7% -$328K 0.38% 61
2014
Q2
$45.1M Sell
799,775
-21,081
-3% -$1.11M 0.36% 68
2014
Q1
$42.2M Sell
820,856
-135,981
-14% -$6.87M 0.36% 69
2013
Q4
$50.5M Sell
956,837
-114,702
-11% -$5.64M 0.4% 59
2013
Q3
$47.9M Sell
1,071,539
-56,822
-5% -$2.52M 0.4% 60
2013
Q2
$46.6M Buy
+1,128,361
New +$49.3M 0.38% 59

Other funds holding ABBV

British Columbia Investment Management's ABBV Position: Q1 2026 in Review

British Columbia Investment Management reduced its AbbVie (ABBV) stake by 22% in Q1 2026, selling an estimated $15.5M and leaving 243,587 shares worth $53M. The position accounts for 0.31% of the portfolio, ranked #57.

British Columbia Investment Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $71.6M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • British Columbia Investment Management held 243,587 shares of AbbVie worth $53M as of Q1 2026.
  • British Columbia Investment Management sold 69,837 AbbVie shares in Q1 2026, an estimated $15.5M.
  • AbbVie made up 0.31% of British Columbia Investment Management's portfolio in Q1 2026, its #57 holding.
  • British Columbia Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • British Columbia Investment Management's AbbVie position peaked at $71.6M in Q4 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on British Columbia Investment Management's 13F filing for Q1 2026, filed 14 May 2026.